These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9632302)

  • 1. Accelerated fractionation (AF) in head and neck cancers.
    Esassolak M; Yalman D; Anacak Y; Ozkök S; Haydaroğlu A
    Radiother Oncol; 1998 Apr; 47(1):103-4. PubMed ID: 9632302
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated fractionation (AF) in head and neck cancers.
    Fowler J
    Radiother Oncol; 1998 Apr; 47(1):104-7. PubMed ID: 9632303
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated fractionation (AF) in head and neck cancers.
    Jones B; Dale RG
    Radiother Oncol; 1998 Apr; 47(1):107-8. PubMed ID: 9632304
    [No Abstract]   [Full Text] [Related]  

  • 4. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
    Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
    Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in high-technology radiotherapy for head and neck cancer.
    Kubicek GJ; Machtay M
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1165-80, viii. PubMed ID: 19010266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated and hyperfractionated radiotherapy in advanced head and neck tumors: rebuttal.
    Nguyen TD
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):212. PubMed ID: 3335457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
    Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
    Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
    Saunders MI; Rojas AM; Parmar MK; Dische S;
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
    Logie MB
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to survival rate improvement].
    Hatano K; Sakai M; Araki H; Imagunbai T
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1833-6. PubMed ID: 19011331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of head and neck cancer.
    Evans RA
    N Engl J Med; 1998 Oct; 339(18):1330; author reply 1331. PubMed ID: 9841298
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel radiotherapy schedules aid recovery of normal tissues after treatment.
    Fowler JF
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):7-8. PubMed ID: 20361066
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in radiotherapy for carcinoma of the head and neck.
    Morris MM; Schmidt-Ullrich R; Johnson CR
    Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
    Horiot JC
    Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
    Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
    Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of head and neck cancer.
    Tobias JS
    N Engl J Med; 1998 Oct; 339(18):1330-1. PubMed ID: 9841300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.